Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 53.00%531.82M | 33.68%315.89M | 47.68%155.78M | 27.73%502.49M | 15.44%347.59M | 15.42%236.31M | 9.25%105.49M | 1.67%393.39M | 2.92%301.1M | -4.02%204.74M |
| Operating revenue | 53.00%531.82M | 33.68%315.89M | 47.68%155.78M | 27.73%502.49M | 15.44%347.59M | 15.42%236.31M | 9.25%105.49M | 1.67%393.39M | 2.92%301.1M | -4.02%204.74M |
| Other operating revenue | ---- | 82.43%220.24K | ---- | -29.20%257.1K | ---- | -33.49%120.73K | ---- | 20.49%363.12K | ---- | 73.10%181.52K |
| Total operating cost | 58.43%483.42M | 39.64%287.57M | 50.08%140.02M | 31.82%444.23M | 19.58%305.13M | 19.24%205.93M | 16.23%93.3M | 9.51%337M | 9.28%255.17M | 2.32%172.71M |
| Operating cost | 57.02%437.38M | 36.86%258.64M | 48.98%127.23M | 30.97%402.55M | 18.19%278.56M | 17.68%188.97M | 13.86%85.4M | 9.23%307.35M | 9.81%235.69M | 3.38%160.58M |
| Operating tax surcharges | 39.25%4.27M | 36.36%2.79M | 35.87%1.38M | 19.18%4.51M | 246.46%3.07M | 355.06%2.05M | 459.85%1.02M | 251.55%3.78M | 10.62%886.09K | -36.61%449.86K |
| Operating expense | 88.53%2.51M | 97.05%1.7M | 36.16%564.44K | 8.69%2.42M | 7.24%1.33M | 0.21%860.44K | -3.36%414.53K | 13.88%2.23M | 8.96%1.24M | 21.32%858.64K |
| Administration expense | 69.89%13.29M | 60.32%8.62M | 33.97%3.67M | 32.73%13.26M | -9.16%7.82M | -2.95%5.38M | 21.71%2.74M | 13.55%9.99M | 42.45%8.61M | 32.28%5.54M |
| Financial expense | 693.33%6.11M | 18,091.10%3.74M | 837.06%1.63M | 155.60%2.03M | 123.38%770.18K | 100.75%20.56K | 85.82%-220.87K | -40.48%-3.66M | -325.80%-3.29M | -800.53%-2.75M |
| -Interest expense (Financial expense) | 261.18%6.3M | 358.97%3.88M | --1.68M | ---- | --1.75M | --845.53K | ---- | ---- | ---- | ---- |
| -Interest Income (Financial expense) | 80.19%-199.88K | 83.11%-143.95K | 91.22%-51.17K | ---- | 69.50%-1.01M | 69.10%-852.44K | 62.82%-582.67K | ---- | -323.80%-3.31M | -787.95%-2.76M |
| Research and development | 46.27%19.85M | 39.61%12.08M | 40.43%5.55M | 12.45%19.46M | 12.77%13.57M | 7.89%8.65M | -0.38%3.95M | 0.93%17.31M | 3.24%12.04M | -1.58%8.02M |
| Credit Impairment Loss | -132.12%-1.6M | -13.20%-1.44M | -42.85%-1.41M | -184.32%-1.56M | 29.12%-691.09K | 10.14%-1.27M | 35.93%-985.08K | -1,156.27%-549.54K | -603.42%-975.07K | -436.80%-1.41M |
| Asset Impairment Loss | -23.54%-258.11K | 64.68%-66K | 83.47%-17.67K | -4,033.20%-3.43M | -246.86%-208.93K | -495.92%-186.88K | -312.49%-106.9K | -42.41%-82.93K | 38.20%-60.23K | 61.40%-31.36K |
| Other net revenue | -25.31%1.31M | 85.36%1.4M | 3.29%-456.23K | -161.18%-1.68M | -20.55%1.75M | -50.53%752.92K | -11.87%-471.76K | -88.71%2.74M | -90.13%2.2M | -90.64%1.52M |
| Invest income | -81.00%236.7K | -53.52%578.87K | ---307.77K | -3.24%1.2M | -9.52%1.25M | -9.52%1.25M | ---- | -90.62%1.24M | -89.15%1.38M | -85.24%1.38M |
| -Including: Investment income associates | ---- | ---- | ---- | 63.44%-43.45K | ---- | ---- | ---- | ---118.84K | ---- | ---- |
| Asset deal income | --337.26K | ---- | ---- | ---- | ---- | ---- | ---- | ---35.24K | ---36.02K | ---36.02K |
| Other revenue | 84.64%2.6M | 140.61%2.32M | 105.81%1.28M | -2.77%2.11M | -25.97%1.41M | -40.69%964.5K | -47.94%620.22K | -80.58%2.17M | -80.78%1.9M | -77.64%1.63M |
| Operating profit | 12.42%49.71M | -4.51%29.72M | 30.61%15.3M | -4.32%56.58M | -8.13%44.22M | -7.24%31.13M | -26.17%11.71M | -42.87%59.13M | -40.87%48.13M | -44.78%33.55M |
| Add:Non operating Income | --5.54K | --5.4K | ---- | ---- | ---- | ---- | ---- | --38.51K | --328.75K | --780.58 |
| Less:Non operating expense | --143.29K | --124.54K | --4.81 | -82.21%500K | ---- | ---- | ---- | 167.63%2.81M | 1,990.02%209K | -94.82%517.99 |
| Total profit | 12.11%49.57M | -4.89%29.6M | 30.61%15.3M | -0.50%56.08M | -8.36%44.22M | -7.24%31.13M | -26.17%11.71M | -44.99%56.36M | -40.71%48.25M | -44.77%33.55M |
| Less:Income tax cost | -3.82%4.11M | -22.72%2.35M | 0.20%1.62M | -12.30%5.14M | -13.41%4.28M | -9.63%3.04M | 0.80%1.61M | -46.26%5.86M | -54.65%4.94M | -61.39%3.37M |
| Net profit | 13.82%45.46M | -2.96%27.25M | 35.46%13.68M | 0.87%50.95M | -7.78%39.94M | -6.97%28.08M | -29.19%10.1M | -44.84%50.51M | -38.56%43.31M | -41.99%30.19M |
| Net profit from continuing operation | 13.82%45.46M | -2.96%27.25M | 35.46%13.68M | 0.87%50.95M | -7.78%39.94M | -6.97%28.08M | -29.19%10.1M | -44.84%50.51M | -38.56%43.31M | -41.99%30.19M |
| Net profit of parent company owners | 13.82%45.46M | -2.96%27.25M | 35.46%13.68M | 0.87%50.95M | -7.78%39.94M | -6.97%28.08M | -29.19%10.1M | -44.84%50.51M | -38.56%43.31M | -41.99%30.19M |
| Earning per share | ||||||||||
| Basic earning per share | 13.82%0.4546 | -2.96%0.2725 | 35.45%0.1368 | 0.00%0.51 | -7.78%0.3994 | -6.99%0.2808 | -27.86%0.101 | -44.57%0.51 | -38.56%0.4331 | -41.99%0.3019 |
| Diluted earning per share | 13.82%0.4546 | -2.96%0.2725 | 35.45%0.1368 | 0.00%0.51 | -7.78%0.3994 | -6.99%0.2808 | -27.86%0.101 | -44.57%0.51 | -38.56%0.4331 | -41.99%0.3019 |
| Other composite income | ||||||||||
| Total composite income | 13.82%45.46M | -2.96%27.25M | 35.46%13.68M | 0.87%50.95M | -7.78%39.94M | -6.97%28.08M | -29.19%10.1M | -44.84%50.51M | -38.56%43.31M | -41.99%30.19M |
| Total composite income of parent company owners | 13.82%45.46M | -2.96%27.25M | 35.46%13.68M | 0.87%50.95M | -7.78%39.94M | -6.97%28.08M | -29.19%10.1M | -44.84%50.51M | -38.56%43.31M | -41.99%30.19M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.